VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat severe lung injuries in a less invasive way. Why it matters: The medical ...

57 percent for patients with circulatory support by VA-ECMO alone, 48 percent with intrahospital systemic thrombolysis, 43 percent for percutaneous catheter-directed treatment, ...